Beta Drugs Ltd (BETA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1002857,
    "name": "Beta Drugs Ltd",
    "stock_name": "Beta Drugs Ltd",
    "full_name": "Beta Drugs Ltd",
    "name_url": "stocks-analysis/beta-drugs",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,093.40",
    "chg": -94.4,
    "chgp": "-4.31%",
    "dir": -1,
    "prev_price": "2,187.80",
    "mcapval": "2,421.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "BETA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE351Y01019",
    "curr_date": "Sep 24, 03:30 PM",
    "curr_time": "08:23 AM",
    "last_traded_at": "Sep 24, 03:30 PM IST",
    "bse_nse_vol": 16148,
    "exc_status": "Active",
    "traded_date": "Sep 24, 2026",
    "traded_date_str": "2026 09 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/beta-drugs-1002857-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Beta Drugs Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/beta-drugs-ltd-is-rated-hold-by-marketsmojo-4194904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BetaDrugsLtd_mojoScore_4194904.png",
        "date": "2026-09-16 10:10:36",
        "description": "Beta Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 16 September 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Beta Drugs Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/beta-drugs-ltd-is-rated-hold-by-marketsmojo-4183164",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BetaDrugsLtd_mojoScore_4183164.png",
        "date": "2026-09-05 10:10:29",
        "description": "Beta Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 September 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Beta Drugs Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/beta-drugs-ltd-technical-momentum-shifts-amid-mixed-market-signals-4178693",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BetaDrugsLtd_technicaldot_4178693.png",
        "date": "2026-09-02 08:08:27",
        "description": "Beta Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent day decline of 2.35%, the stock’s longer-term technical indicators reveal a complex interplay of bullish and bearish signals, prompting a reassessment of its market positioning and investment appeal."
      },
      {
        "title": "Beta Drugs Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/beta-drugs-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-strong-returns-4176908",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BetaDrugsLtd_technicaldot_4176908.png",
        "date": "2026-09-01 08:06:28",
        "description": "Beta Drugs Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by robust price action and supportive technical indicators, reflecting the company’s strong performance in the Pharmaceuticals & Biotechnology sector. With a current market price of ₹2,259.90 and a year-to-date return of 45.9%, Beta Drugs is attracting renewed investor interest despite its micro-cap status."
      },
      {
        "title": "Beta Drugs Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/beta-drugs-ltd-technical-momentum-shifts-amid-mixed-market-signals-4170914",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BetaDrugsLtd_technicaldot_4170914.png",
        "date": "2026-08-27 08:04:16",
        "description": "Beta Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent day decline of 1.15%, the stock’s broader technical indicators reveal a complex interplay of bullish and bearish signals, reflecting both resilience and caution in its price action."
      },
      {
        "title": "Beta Drugs Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/beta-drugs-ltd-is-rated-hold-by-marketsmojo-4168762",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BetaDrugsLtd_mojoScore_4168762.png",
        "date": "2026-08-25 10:10:04",
        "description": "Beta Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 August 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Beta Drugs Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/beta-drugs-ltd-is-rated-hold-by-marketsmojo-4153577",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BetaDrugsLtd_mojoScore_4153577.png",
        "date": "2026-08-14 10:10:03",
        "description": "Beta Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 August 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Beta Drugs Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/beta-drugs-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-strong-returns-4146518",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BetaDrugsLtd_technicaldot_4146518.png",
        "date": "2026-08-11 08:08:01",
        "description": "Beta Drugs Ltd has demonstrated a significant shift in price momentum, supported by a series of bullish technical indicators that have upgraded its outlook from a Sell to a Hold rating. The pharmaceutical micro-cap has outperformed the broader market indices, signalling renewed investor interest and potential for sustained growth."
      },
      {
        "title": "Beta Drugs Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/beta-drugs-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-4137112",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BetaDrugsLtd_technicaldot_4137112.png",
        "date": "2026-08-05 08:06:34",
        "description": "Beta Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. This change accompanies impressive price returns that have outpaced the Sensex across multiple timeframes, signalling renewed investor interest and potential for sustained growth."
      }
    ],
    "total": 92,
    "sid": "1002857",
    "stock_news_url": "https://www.marketsmojo.com/news/beta-drugs-1002857"
  },
  "announcements": [
    {
      "details": "Beta Drugs Limited has informed the Exchange regarding 'International Plant Approvals'.",
      "source": "NSE",
      "caption": "Beta Drugs Limited - Updates",
      "datetime": "15-Nov-2019"
    },
    {
      "details": "Beta Drugs Limitedgs Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Beta Drugs Limited - Reply to Clarification- Financial results",
      "datetime": "14-Nov-2019"
    },
    {
      "details": "Beta Drugs Limiteded for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Beta Drugs Limited - Clarification - Financial Results",
      "datetime": "08-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Beta Drugs Ltd has announced <strong>1:20</strong> bonus issue, ex-date: 26 Mar 25",
          "dt": "2025-03-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Beta Drugs Ltd is Rated Hold by MarketsMOJO

2026-09-16 10:10:36

Beta Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 16 September 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Beta Drugs Ltd is Rated Hold by MarketsMOJO

2026-09-05 10:10:29

Beta Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 September 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Beta Drugs Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-09-02 08:08:27

Beta Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent day decline of 2.35%, the stock’s longer-term technical indicators reveal a complex interplay of bullish and bearish signals, prompting a reassessment of its market positioning and investment appeal.

Read full news article

Beta Drugs Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Strong Returns

2026-09-01 08:06:28

Beta Drugs Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by robust price action and supportive technical indicators, reflecting the company’s strong performance in the Pharmaceuticals & Biotechnology sector. With a current market price of ₹2,259.90 and a year-to-date return of 45.9%, Beta Drugs is attracting renewed investor interest despite its micro-cap status.

Read full news article

Beta Drugs Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-08-27 08:04:16

Beta Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent day decline of 1.15%, the stock’s broader technical indicators reveal a complex interplay of bullish and bearish signals, reflecting both resilience and caution in its price action.

Read full news article

Beta Drugs Ltd is Rated Hold by MarketsMOJO

2026-08-25 10:10:04

Beta Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 August 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Beta Drugs Ltd is Rated Hold by MarketsMOJO

2026-08-14 10:10:03

Beta Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 August 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Beta Drugs Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Strong Returns

2026-08-11 08:08:01

Beta Drugs Ltd has demonstrated a significant shift in price momentum, supported by a series of bullish technical indicators that have upgraded its outlook from a Sell to a Hold rating. The pharmaceutical micro-cap has outperformed the broader market indices, signalling renewed investor interest and potential for sustained growth.

Read full news article

Beta Drugs Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook

2026-08-05 08:06:34

Beta Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. This change accompanies impressive price returns that have outpaced the Sensex across multiple timeframes, signalling renewed investor interest and potential for sustained growth.

Read full news article

View All News